Also trades as: 0QAH.L (LSE) · $vol 8M · 6MK.DE (XETRA) · $vol 0M · MRK.PA (PAR) · $vol 0M

$122.41

+6.53 (+5.64%)

Weekly Expected Move ±3.4%

$104 $108 $111 $115 $119

NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 67 · $302.3B mcap · 2.47B float · 0.386% daily turnover · Short 45% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$65.0B +1.3% ▲

5Y CAGR: +9.4%

Gross Profit

$53.0B +8.2% ▲

5Y CAGR: +13.7%

Operating Income

$26.8B +32.4% ▲

5Y CAGR: +37.0%

Net Income

$18.3B +6.6% ▲

5Y CAGR: +20.9%

EPS (Diluted)

$7.28 +8.0% ▲

5Y CAGR: +21.2%

EBITDA

$25.4B -1.3% ▼

5Y CAGR: +20.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$48.7B	$59.3B	$60.1B	$64.2B	$65.0B
YoY Growth	+17.3%	+21.7%	+1.4%	+6.7%	+1.3%
Cost of Revenue	$13.6B	$17.4B	$16.1B	$15.2B	$12.0B
Gross Profit	$35.1B	$41.9B	$44.0B	$49.0B	$53.0B
Gross Margin	72.0%	70.6%	73.2%	76.3%	81.5%
R&D Expenses	$12.2B	$13.5B	$30.5B	$17.9B	$15.6B
SG&A Expenses	$9.4B	$9.7B	$9.9B	$10.1B	$10.6B
Operating Expenses	$21.9B	$23.6B	$41.0B	$28.8B	$26.2B
Operating Income	$13.2B	$18.3B	$3.0B	$20.2B	$26.8B
Operating Margin	27.1%	30.8%	4.9%	31.5%	41.2%
Interest Expense	$806M	$962M	$1.1B	$1.3B	$0
Income Before Tax	$13.9B	$16.4B	$1.9B	$19.9B	$21.1B
Tax Expense	$1.5B	$1.9B	$1.5B	$2.8B	$2.8B
Net Income	$13.0B	$14.5B	$365M	$17.1B	$18.3B
Net Margin	26.8%	24.5%	0.6%	26.7%	28.1%
EPS (Diluted)	$5.14	$5.71	$0.14	$6.74	$7.28
EBITDA	$17.9B	$21.3B	$6.9B	$25.7B	$25.4B
Shares Outstanding	2.54B	2.54B	2.55B	2.54B	2.51B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$16.1B	$16.7B	$15.6B	$15.5B	$15.8B	$17.3B	$16.3B	$16.3B
Cost of Revenue	$3.7B	$4.1B	$3.8B	$3.4B	$3.6B	$3.9B	$4.8B	$2.9B
Gross Profit	$12.4B	$12.6B	$11.8B	$12.1B	$12.2B	$13.4B	$11.5B	$13.3B
Gross Margin	76.8%	75.5%	75.5%	78.0%	77.5%	77.7%	70.5%	81.9%
R&D Expenses	$3.5B	$5.9B	$4.6B	$3.6B	$4.0B	$4.2B	$2.5B	$12.6B
SG&A Expenses	$2.7B	$2.7B	$2.7B	$2.6B	$2.6B	$2.6B	$2.8B	$2.7B
Operating Expenses	$6.2B	$8.6B	$7.4B	$6.2B	$6.7B	$6.9B	$5.3B	$15.2B
Operating Income	$6.1B	$4.0B	$4.3B	$5.9B	$5.6B	$6.6B	$6.2B	-$1.9B
Operating Margin	38.0%	23.9%	27.8%	38.2%	35.1%	37.9%	37.7%	-11.6%
Interest Expense	$310M	$330M	$328M	$313M	$305M	$327M	$411M	$0
Income Before Tax	$6.0B	$4.1B	$4.2B	$5.9B	$5.0B	$6.7B	$3.4B	-$3.5B
Tax Expense	$545M	$929M	$426M	$818M	$571M	$958M	$458M	$709M
Net Income	$5.5B	$3.2B	$3.7B	$5.1B	$4.4B	$5.8B	$3.0B	-$4.2B
Net Margin	33.9%	19.0%	24.0%	32.7%	28.0%	33.5%	18.2%	-26.0%
EPS (Diluted)	$2.14	$1.24	$1.48	$2.01	$1.76	$2.32	$1.19	$-1.72
EBITDA	$7.4B	$5.6B	$5.7B	$7.3B	$6.4B	$8.2B	$8.6B	-$1.9B
Shares Outstanding	2.54B	2.54B	2.54B	2.53B	2.51B	2.50B	2.49B	2.47B

MRK NYSE